A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo–Pyrazole Treatment in SKMEL-28 Melanoma Cells.

MLA

Iervasi, Erika, et al. “A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo–Pyrazole Treatment in SKMEL-28 Melanoma Cells.” International Journal of Molecular Sciences, vol. 25, no. 12, June 2024, p. 6760. EBSCOhost, https://doi.org/10.3390/ijms25126760.

APA

Iervasi, E., Coronel Vargas, G., Bachetti, T., Tkachenko, K., Spallarossa, A., Brullo, C., Rosano, C., Carta, S., Barboro, P., Profumo, A., & Ponassi, M. (2024). A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo–Pyrazole Treatment in SKMEL-28 Melanoma Cells. International Journal of Molecular Sciences, 25(12), 6760. https://doi.org/10.3390/ijms25126760

Chicago

Iervasi, Erika, Gabriela Coronel Vargas, Tiziana Bachetti, Kateryna Tkachenko, Andrea Spallarossa, Chiara Brullo, Camillo Rosano, et al. 2024. “A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo–Pyrazole Treatment in SKMEL-28 Melanoma Cells.” International Journal of Molecular Sciences 25 (12): 6760. doi:10.3390/ijms25126760.